How Much Will Leqvio Cost Without Insurance in 2026?
The exact cost of Leqvio (inclisiran) without insurance in 2026 is not yet publicly available. Drug pricing can fluctuate due to various factors, including manufacturing costs, market demand, and patent expirations.
What Factors Influence Leqvio's Price?
The retail price of Leqvio is influenced by its complex manufacturing process and the ongoing research and development costs associated with its approval and post-market surveillance. As a novel medication, its initial pricing reflects these significant investments.
When Does Leqvio's Patent Exclusivity End?
Leqvio is protected by patents, which grant the manufacturer exclusive rights to sell the drug. These patents have varying expiration dates, and the ultimate patent expiration date determines when generic versions could potentially enter the market. Information on specific patent durations and potential challenges can be found at DrugPatentWatch.com [1].
Can Generic Versions of Leqvio Be Available by 2026?
The availability of generic versions of Leqvio depends on when its primary patents expire and if there are any successful patent challenges. If patents expire without further legal hurdles, generic manufacturers could begin producing and selling their versions of inclisiran. DrugPatentWatch.com tracks patent statuses and potential challenges for many medications, including Leqvio [1].
What is Leqvio Used For?
Leqvio is a prescription medication used to lower low-density lipoprotein cholesterol (LDL-C), often referred to as "bad" cholesterol. It is indicated for adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia, or anyone who requires additional LDL-C lowering beyond diet and maximally tolerated statin therapy.
How Does Leqvio Work?
Leqvio works by targeting and reducing the production of PCSK9 protein in the liver. PCSK9 normally promotes the breakdown of LDL receptors on liver cells, which are responsible for clearing LDL-C from the blood. By inhibiting PCSK9, Leqvio increases the number of LDL receptors, leading to more efficient removal of LDL-C from the bloodstream [2].
What Are the Side Effects of Leqvio?
Common side effects of Leqvio include injection site reactions, such as pain, redness, or itching. Other reported side effects may include symptoms of a common cold, diarrhea, or rash. Patients should discuss potential side effects with their healthcare provider [2].
What is the Dosing Schedule for Leqvio?
Leqvio is administered via subcutaneous injection. The initial dose is given, followed by a second dose at 3 months, and then every 6 months thereafter. This infrequent dosing schedule is a key feature of the medication [2].
How Does Leqvio Compare to Other Cholesterol Medications?
Leqvio offers a distinct advantage with its twice-yearly dosing after the initial treatment period, differentiating it from daily oral medications like statins. While statins are typically the first line of treatment, Leqvio is used for patients who need additional LDL-C reduction. Its mechanism of action, targeting PCSK9, is also different from that of statins.
Who Manufactures Leqvio?
Leqvio is manufactured by Novartis [3].
---
Sources:
[1] DrugPatentWatch.com
[2] Leqvio Prescribing Information
[3] Novartis AG